日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

Global EditionASIA 中文雙語Fran?ais
Opinion
Home / Opinion / Opinion Line

No tariffs on targeted cancer drugs will reduce the price pain for patients

China Daily | Updated: 2018-03-22 07:07
Share
Share - WeChat

Premier Li Keqiang promises zero tariff rates for targeted cancer drugs at a news conference after the two sessions in Beijing on Tuesday. Thepaper.cn comments:

It is estimated more than 2 million people die of cancer in China each year. If there are zero tariffs, the retail price of the imported lifesaving drugs used in targeted cancer therapies will drop markedly. Their high prices have resulted in a large number of cancer patients exhausting their savings to extend their lives for a short time.

Some imported targeted cancer therapies can cost a patient as much as 10,000 yuan ($1,579) a dose as they are not covered by the medical insurance system. The high prices mean many patients have to give up their treatment.

More and more patients have turned to buying medicines from India through various channels as the prices are much lower, or to generic drugs that are lower in both price and efficiency. They then take the medicines at home without professional instruction and monitoring, further risking their health.

Aside from the tariffs, the high retail price of imported drugs in China is also pushed up by agents' fees, value-added tax, and high basic prices, which stem from the super-national treatment that some foreign medicines have been enjoying in the drug procurement of public hospitals, even if some of their patent protections have expired.

The pledge to end the tariffs on targeted cancer therapies indicates that the government recognizes they are special goods concerning people's welfare. But even without the tariffs, there still remains considerable room to squeeze the profit links between customs and patients to further bring down the prices of the drugs.

That the government has to open doors to imported drugs to save people's lives should also ring alarm bells for domestic pharmaceutical companies, especially the State-owned ones, as they have no reasons to sit idle, and are obliged to strengthen their research into these badly needed medicines and try their best to acquire the ability of producing them as early as possible.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 国产成人精品综合在线观看 | 蜜桃91丨九色丨蝌蚪91桃色 | 五月婷婷视频在线观看 | 久久女人天堂 | 93久久精品日日躁夜夜躁欧美 | 在线毛片观看 | 黄色理论视频 | 国产在线视频自拍 | 国产免费一级视频 | av网址在线 | 色啪影院 | 麻豆天堂| 日韩视频精品在线 | www午夜 | 日韩午夜精品 | 日韩欧美激情视频 | 97在线免费观看视频 | 久操91| 男人的天堂久久 | 精品一级 | 国产黄网在线观看 | 不卡视频在线观看 | 少妇性l交大片7724com | 国内性爱视频 | www.色中色 | 在线天堂v| 久久久久精 | 操你啦在线视频 | 日产精品久久久一区二区 | 在线超碰av | 国产视频一二区 | 琪琪久久 | 狼窝色中色 | 亚洲欧美日韩综合在线 | 中文字幕av高清 | 久久久久免费看 | 日本不卡影院 | 久久久91 | 国产超碰在线观看 | 国产激情网站 | 亚洲二区视频 |